2022 the Academy Distinguished Abstracts Winners

The the Academy of Diagnostics & Laboratory Medicine is pleased to announce the winners of the 2022 Distinguished Abstracts Awards. A group of Fellows selected these 19 abstracts for their scientific excellence from a pool of more than 640 abstracts accepted for the the Association for Diagnostics & Laboratory Medicine (formerly AACC) Annual Scientific Meeting.

Winning abstracts displayed the Academy blue ribbon during the the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting poster sessions.


A-010 - Jeffrey Chang, MD, Birmingham, AL
Comparison of eGFR Calculated by MDRD Equation and the 2021 CKD-EPI without Race Equation

A-061 - Robert Maynard, PhD, Chapel Hill, NC
Concordance of Chronic Kidney Disease Stage and Metformin Management Using CKD-EPI 2021 Race-Free Equation vs. CKD-EPI 2009 Equation to Estimate Glomerular Filtration Rate

A-077 - Kimia Sobhani, PhD, Los Angeles, CA
Longitudinal Analysis of Characteristics Associated with Variable Antibody Response to BNT162b2 Vaccination Among Healthcare Workers over Ten Months

A-107 - Ayaka Ikenaga, Tokyo, Japan (ePoster only)
Chymase truncation of apolipoprotein E in high-density lipoprotein is further promoted under myeloperoxidase oxidation

A-160 - Guanmin Chen, MD, Cleveland, OH
RNase L Contributes to the Development of Nonalcoholic Steatohepatitis (NASH) by Regulating the Expression of the Key Genes Involved in Lipid Metabolism, Immune Responses, and Fibrosis Signaling

A-161 - Anil Chokkalla, PhD, Madison, WI
Clinical utility of RNA chemical modifications as biomarkers for acute ischemic stroke

A-210 - Kyounghoon Suh, PhD, Daejeon, Korea
Clinical Evaluation of Thioredoxin 1 in the Blood as a Novel Biomarker to Detect Breast Cancer

A-226 - Nicholas Pinkhover, Gent, Boston, MA
Performance of PCR-based Genotyping Panel and Whole Genome Sequencing for SARS-CoV-2 Variant Identification in Low Viral Load Samples

A-253 - Jennifer Power Carson, PhD, Saint Louis, MO
Glycated Albumin During Pregnancy: Preliminary Reference Intervals for a Midwestern U.S. Population and Usefulness as a Predictor of Adverse Neonatal Events

A-293 - Theresa Swift, MA/MS, Ann Arbor, MI
Changes in phosphatidylethanol positivity after transfusion and potential impact on interpretation of alcohol use.

A-295 - Grace Williams, PhD, Richmond, VA
Potential Detection of 58 Fentanyl Analogs in Urine using Fentanyl Immunoassays

A-304 - Natália Custódio, MA/MS, Belo Horizonte, Brazil (ePoster Only)
Analysis of Membrane Transporter Genes as Prognostic Tools and Predictors of Response to Chemoradiation Therapy in Patients with Cervical Cancer

B-023 - Rachel DeHoog, Houston, TX
Desorption Electrospray Ionization Mass Spectrometry Imaging as a Tool for Preoperative Classification of Thyroid Nodules

B-049 - Pankaj Kumar, Vancouver, Canada
Comparison of diagnostic performance of combined CSF biomarkers with plasma p-tau181 concentrations in predicting clinically diagnosed Alzheimer’s disease

B-053 - Danting Liu, PhD, Memphis, TN
Deep Single-cell Type Proteome Profiling of Mouse Brain from Alzheimer's Disease Model by Nano-scale Tandem Mass Tag Mass Spectrometry

B-069 - Danielle Ronnow, Salt Lake City, UT
Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry

B-111 - Yang Luo, Chongging, China (ePoster only)
DNAzyme Encapsulated Nano-vesicle for Non-Destructive Detection of Exosomal miRNA

B-130 - Akhil Bhargava, MA/MS, Chicago, IL
Assessment of a Combined Biomarker-EMR Data Machine Learning Model for Sepsis-3

B-183 - Kelly Michaelsen MD/PhD, Seattle, WA (ePoster only)
Micro-mechanical PT/INR testing using smartphones

B-243 - Jingcai Wang, PhD, Columbus, OH
Evaluation of a prediction algorithm value in predicting positive urine culture in pediatrics: a retrospective cohort study at Nationwide Children’s Hospital

Academy of Diagnostics & Laboratory Medicine Designation

Fellows of the Academy use the designation of FADLM. This designation is equivalent to FACB and FAACC, the previous designations used by fellows of the National Academy of Clinical Biochemistry and AACC Academy. Those groups were rebranded as Academy of Diagnostics & Laboratory Medicine in 2023.